Ceftobiprole: breaking therapeutic dogmas of the beta-lactam class.
Deresinski
Stanley C
SC
Stanford University Medical Center, San Jose, CA 94062, USA. polishmd@earthlink.net
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001424:Bacterial Infections / Q000188:drug therapy; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; C443755:ceftobiprole